デフォルト表紙
市場調査レポート
商品コード
1387274

RNA分析/トランスクリプトミクスの世界市場：動向、予測、競合分析（～2030年）

RNA Analysis/Transcriptomics Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.10円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

RNA分析/トランスクリプトミクスの世界市場：動向、予測、競合分析（～2030年）
出版日: 2023年10月31日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

RNA分析/トランスクリプトミクスの動向と予測

世界のRNA分析/トランスクリプトミクスの市場規模は、2024～2030年にかけてCAGR 10.5%で成長し、2030年までに約123億米ドルに達すると予測されています。この市場の主な促進要因は、個別化医療に対する需要の高まりと、製薬・バイオ産業の継続的成長です。世界のRNA分析/トランスクリプトミクス市場の将来は、政府機関・学術センター、製薬・バイオテクノロジー、病院・診療所、医薬品開発業務受託機関市場にビジネスチャンスがあり、有望視されています。

RNA分析/トランスクリプトミクス市場の洞察

Lucintelの予測によると、創薬は、この用途におけるターゲットシーケンスベースのアプローチの人気の高まりにより、予測期間中に最も高い成長が見込まれます。

北米は、構造ベースの薬剤設計に対する嗜好の高まりと、同地域に大手製薬企業やバイオファーマ企業が存在することから、引き続き最大地域となります。

本レポートでは、以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがあるか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のRNA分析/トランスクリプトミクス市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析：2018～2030年

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のRNA分析/トランスクリプトミクス市場動向（2018～2023年）と予測（2024～2030年）
  • 世界のRNA分析/トランスクリプトミクス市場：製品タイプ別
    • 消耗品
    • 機器
    • ソフトウェア
    • サービス
  • 世界のRNA分析/トランスクリプトミクス市場：技術別
    • リアルタイムPCR（qPCR）
    • マイクロアレイ
    • シーケンス
    • その他
  • 世界のRNA分析/トランスクリプトミクス市場：用途別
    • 創薬
    • 診断・疾患プロファイリング
    • その他
  • 世界のRNA分析/トランスクリプトミクス市場：最終用途別
    • 政府機関・学術センター
    • 製薬・バイオテクノロジー
    • 病院・診療所
    • 医薬品開発業務受託機関
    • その他

第4章 市場動向と予測分析：地域別（2018～2030年）

  • 世界のRNA分析/トランスクリプトミクス市場：地域別
  • 北米のRNA分析/トランスクリプトミクス市場
  • 欧州のRNA分析/トランスクリプトミクス市場
  • アジア太平洋のRNA分析/トランスクリプトミクス市場
  • その他の地域のRNA分析/トランスクリプトミクス市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品タイプ別の世界のRNA分析/トランスクリプトミクス市場の成長機会
    • 技術別の世界のRNA分析/トランスクリプトミクス市場の成長機会
    • 用途別の世界のRNA分析/トランスクリプトミクス市場の成長機会
    • 最終用途別の世界のRNA分析/トランスクリプトミクス市場の成長機会
    • 地域別の世界のRNA分析/トランスクリプトミクス市場の成長機会
  • 世界のRNA分析/トランスクリプトミクス市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のRNA分析/トランスクリプトミクス市場の生産能力拡大
    • 世界のRNA分析/トランスクリプトミクス市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Pacific Bioscience of California
  • Affymetrix
目次

RNA Analysis/Transcriptomics Trends and Forecast

The future of the global RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets. The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.

A more than 150-page report is developed to help in your business decisions.

RNA Analysis/Transcriptomics by Segment

The study includes a forecast for the global RNA analysis/transcriptomics by product type, technology, application, end use, and region.

RNA Analysis/Transcriptomics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Instruments
  • Software
  • Services

RNA Analysis/Transcriptomics Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Real Time-PCR (qPCR)
  • Microarray
  • Sequencing
  • Others

RNA Analysis/Transcriptomics Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Drug Discovery
  • Diagnostics & Disease Profiling
  • Others

RNA Analysis/Transcriptomics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Government Institutes & Academic Centers
  • Pharmaceutical & Biotechnology
  • Hospitals & Clinics
  • Contract Research Organizations (CROs)
  • Others

RNA Analysis/Transcriptomics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of RNA Analysis/Transcriptomics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies RNA analysis/transcriptomics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the RNA analysis/transcriptomics companies profiled in this report include-

  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Pacific Bioscience of California
  • Affymetrix

RNA Analysis/Transcriptomics Market Insights

Lucintel forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.

North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.

Features of the Global RNA Analysis/Transcriptomics Market

Market Size Estimates: RNA analysis/transcriptomics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: RNA analysis/transcriptomics market size by various segments, such as by product type, technology, application, end use, and region in terms of value ($B).

Regional Analysis: RNA analysis/transcriptomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the RNA analysis/transcriptomics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the RNA analysis/transcriptomics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the RNA analysis/transcriptomics market size?

Answer: The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030.

Q2. What is the growth forecast for RNA analysis/transcriptomics market?

Answer: The global RNA analysis/transcriptomics market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the RNA analysis/transcriptomics market?

Answer: The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.

Q4. What are the major segments for RNA analysis/transcriptomics market?

Answer: The future of the RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets.

Q5. Who are the key RNA analysis/transcriptomics market companies?

Answer: Some of the key RNA analysis/transcriptomics companies are as follows:

  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Pacific Bioscience of California
  • Affymetrix

Q6. Which RNA analysis/transcriptomics market segment will be the largest in future?

Answer: Lucintel forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.

Q7. In RNA analysis/transcriptomics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the RNA analysis/transcriptomics market by product type (consumables, instruments, software, and services), technology (real time-pcr (qPCR), microarray, sequencing, and others), application (drug discovery, diagnostics & disease profiling, and others), end use (government institutes & academic centers, pharmaceutical & biotechnology, hospitals & clinics, contract research organizations (CROs), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global RNA Analysis/Transcriptomics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global RNA Analysis/Transcriptomics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global RNA Analysis/Transcriptomics Market by Product Type
    • 3.3.1: Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software
    • 3.3.4: Services
  • 3.4: Global RNA Analysis/Transcriptomics Market by Technology
    • 3.4.1: Real Time-PCR (qPCR)
    • 3.4.2: Microarray
    • 3.4.3: Sequencing
    • 3.4.4: Others
  • 3.5: Global RNA Analysis/Transcriptomics Market by Application
    • 3.5.1: Drug Discovery
    • 3.5.2: Diagnostics & Disease Profiling
    • 3.5.3: Others
  • 3.6: Global RNA Analysis/Transcriptomics Market by End Use
    • 3.6.1: Government Institutes & Academic Centers
    • 3.6.2: Pharmaceutical & Biotechnology
    • 3.6.3: Hospitals & Clinics
    • 3.6.4: Contract Research Organizations (CROs)
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global RNA Analysis/Transcriptomics Market by Region
  • 4.2: North American RNA Analysis/Transcriptomics Market
    • 4.2.1: North American RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
    • 4.2.2: North American RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others
  • 4.3: European RNA Analysis/Transcriptomics Market
    • 4.3.1: European RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
    • 4.3.2: European RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others
  • 4.4: APAC RNA Analysis/Transcriptomics Market
    • 4.4.1: APAC RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
    • 4.4.2: APAC RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others
  • 4.5: ROW RNA Analysis/Transcriptomics Market
    • 4.5.1: ROW RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
    • 4.5.2: ROW RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Product Type
    • 6.1.2: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Technology
    • 6.1.3: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Application
    • 6.1.4: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by End Use
    • 6.1.5: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Region
  • 6.2: Emerging Trends in the Global RNA Analysis/Transcriptomics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global RNA Analysis/Transcriptomics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global RNA Analysis/Transcriptomics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Agilent Technologies
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Illumina
  • 7.4: QIAGEN
  • 7.5: Thermo Fisher Scientific
  • 7.6: Eurofins Scientific
  • 7.7: Merck KGaA
  • 7.8: Bio-Rad Laboratories
  • 7.9: Pacific Bioscience of California
  • 7.10: Affymetrix